FDA Approves Emergency Authorization To Use Anti-Malarial Drugs For COVID-19 Treatment

Written by Wes Walker on March 30, 2020

But don’t expect a mia culpa from all the journos and politicians that gave Trump Hell over speaking hopefully about this treatment option, right?

Ever since the publishing of a peer-reviewed article from a study in France, the eyes of the world have been watching to see whether an old-school anti-malarial treatment would pan out for this virus.

And wouldn’t you know it — it’s gotten emergency approval.

The agency allowed for the drugs to be “donated to the Strategic National Stockpile to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible,” HHS said in a statement, announcing that Sandoz donated 30 million doses of hydroxychloroquine to the stockpile and Bayer donated 1 million doses of chloroquine. — Politico

Naturally, the media site that reported the story above was sure to work in all kinds of gloom-and-doom to downplay any optimism with a treatment that Trump liked.

We wonder whether their attitude would change in light of this claim:

Obviously, we have no way to independently verify the claims they’re making. But on a gut level, if there’s any truth to it, that would be some awesome news for a State that could desperately use some.


WATCH: Actor Daniel Dae Kim Says Hydroxychloroquine Helped Him Recover From Coronavirus

PHARMA: While Corps Contest Trump’s ‘Buy American’ Policy, India Drops A Supply Chain Bombshell

Anti-Trump News Orgs Report That A Man Died ‘Self-Medicating’ On Chloroquine — Here’s What They’re NOT Telling You…

SICK: China Touts A New ‘Cure’ For Coronavirus … This One Is Derived From BEARS